Canada vs Equatorial Guinea: Previously treated cases tested for RR-/MDR-TB
Canada
88.0%
in 2024
Equatorial Guinea
88.0%
in 2024
Canada rank
90th
Equatorial Guinea rank
90th
Previously treated cases tested for RR-/MDR-TB over time
- Canada
- Equatorial Guinea
How they compare
Canada currently reports 88.0% against 88.0% in Equatorial Guinea, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2008 it was Canada ahead.
Canada ranks 90th and Equatorial Guinea ranks 90th of 180 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.0% | 0.0% | 75.0% | Canada |
| 2010s | 77.2% | 39.9% | 37.3% | Canada |
| 2020s | 78.8% | 71.5% | 7.2% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Canada or Equatorial Guinea?
- Canada, at 88.0% against 88.0% in Equatorial Guinea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Canada and Equatorial Guinea?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Equatorial Guinea?
- 10 years are reported by both, from 2008 to 2024.
- How do Canada and Equatorial Guinea rank globally for previously treated cases tested for rr-/mdr-tb?
- Canada ranks 90th and Equatorial Guinea ranks 90th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.